Marc S Sabatine Selected Research

Sodium

4/2024	Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
2/2024	Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials.
11/2023	Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function.
1/2023	Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
1/2023	Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial.
1/2023	Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
1/2022	Relationship of Dapagliflozin With Serum Sodium: Findings From the DAPA-HF Trial.
10/2021	Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index.
1/2021	Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
1/2021	Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc S Sabatine Research Topics

Disease

191	Myocardial Infarction 04/2024 - 04/2002
118	Heart Failure 05/2024 - 05/2004
90	Acute Coronary Syndrome 01/2023 - 04/2002
73	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 04/2002
63	Stroke (Strokes) 04/2024 - 09/2005
50	ST Elevation Myocardial Infarction 01/2022 - 11/2002
47	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2018
41	Hemorrhage 12/2022 - 09/2005
38	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 11/2002
23	Thrombosis (Thrombus) 01/2021 - 07/2002
22	Unstable Angina 01/2023 - 06/2002
19	Ischemic Stroke 02/2024 - 03/2016
19	Ischemia 12/2023 - 04/2003
18	Atherosclerosis 02/2024 - 02/2003
18	Coronary Disease (Coronary Heart Disease) 02/2024 - 02/2003
16	Diabetes Mellitus 12/2023 - 04/2006
15	Peripheral Arterial Disease 02/2024 - 03/2016
15	Infections 01/2023 - 04/2006
13	Hypertension (High Blood Pressure) 01/2023 - 02/2003
12	Atrial Fibrillation 01/2023 - 06/2015
12	Non-ST Elevated Myocardial Infarction 01/2023 - 06/2002
12	Infarction (Infarctions) 01/2022 - 07/2002
11	Myocardial Ischemia (Ischemic Heart Diseases) 09/2016 - 07/2002
10	Hypercholesterolemia 07/2022 - 01/2012
9	Inflammation (Inflammations) 02/2024 - 02/2003
9	Chronic Renal Insufficiency 11/2023 - 04/2006
8	Cardiomyopathies (Cardiomyopathy) 05/2024 - 01/2020
8	Kidney Diseases (Kidney Disease) 10/2023 - 01/2019
6	Obesity 12/2023 - 12/2012
5	Hemorrhagic Stroke 01/2023 - 09/2016
5	Necrosis 01/2023 - 02/2003
5	Vascular Diseases (Vascular Disease) 09/2019 - 03/2016
5	Weight Loss (Weight Reduction) 01/2019 - 01/2018
4	Genetic Risk Score 01/2023 - 10/2019
4	Injection Site Reaction 11/2022 - 01/2017
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 05/2014
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

85	dapagliflozinIBA 05/2024 - 01/2018
47	Clopidogrel (Plavix)FDA Link 11/2022 - 02/2005
45	evolocumabIBA 02/2024 - 01/2012
44	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 06/2006
38	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2002
33	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 02/2003
32	oxidized low density lipoproteinIBA 12/2023 - 11/2005
30	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 04/2002
30	LDL CholesterolIBA 12/2023 - 06/2007
29	omega-Chloroacetophenone (Mace)IBA 04/2024 - 06/2007
28	TicagrelorIBA 01/2023 - 11/2013
25	C-Reactive ProteinIBA 02/2024 - 04/2002
22	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 02/2008
21	Sodium-Glucose Transport ProteinsIBA 10/2023 - 01/2019
18	SodiumIBA 04/2024 - 01/2018
17	Troponin IIBA 01/2021 - 04/2002
16	Proprotein Convertase 9IBA 12/2023 - 08/2013
16	Pravastatin (Pravachol)FDA LinkGeneric 09/2015 - 11/2005
15	LipidsIBA 12/2023 - 01/2012
15	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 01/2018
15	Heparin (Liquaemin)FDA LinkGeneric 03/2021 - 03/2005
13	Troponin T (Troponin T1)IBA 01/2022 - 01/2006
13	Glycoproteins (Glycoprotein)IBA 01/2020 - 11/2002
13	Atorvastatin (Lipitor)FDA Link 09/2019 - 04/2006
12	pro-brain natriuretic peptide (1-76)IBA 12/2023 - 07/2007
11	otamixabanIBA 01/2023 - 09/2009
10	TroponinIBA 01/2022 - 01/2006
10	CholesterolIBA 01/2022 - 11/2005
10	Tirofiban (Aggrastat)FDA Link 11/2020 - 07/2002
10	Prasugrel Hydrochloride FDA Link 01/2020 - 01/2009
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2008
8	CreatinineIBA 10/2023 - 03/2009
7	Lipoprotein(a)IBA 02/2024 - 08/2013
7	Eptifibatide (Integrilin)FDA Link 03/2021 - 09/2009
7	Neurofibromin 2 (Merlin)IBA 01/2021 - 03/2010
7	Enoxaparin (Lovenox)FDA LinkGeneric 03/2009 - 06/2002
6	SymportersIBA 04/2024 - 01/2019
6	Natriuretic PeptidesIBA 12/2023 - 11/2004
6	DiureticsIBA 01/2023 - 02/2008
6	Troleandomycin (TAO)FDA Link 01/2023 - 09/2013
6	Ranolazine FDA Link 01/2021 - 03/2010
6	Cytochrome P-450 CYP2C19IBA 01/2016 - 01/2009
5	HDL CholesterolIBA 04/2024 - 03/2016
5	Monoclonal AntibodiesIBA 12/2023 - 01/2012
5	AlbuminsIBA 10/2023 - 01/2019
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2021 - 01/2016
5	trandolapril (Mavik)FDA LinkGeneric 01/2019 - 03/2007
4	Triglycerides (Triacylglycerol)IBA 04/2024 - 06/2011
4	AnticoagulantsIBA 11/2022 - 09/2013
4	vorapaxarIBA 08/2022 - 10/2012
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2022 - 12/2005
4	HDL LipoproteinsIBA 01/2022 - 01/2019
4	saxagliptin FDA Link 11/2021 - 11/2019
4	Simvastatin (Zocor)FDA LinkGeneric 10/2021 - 07/2006
4	lorcaserinIBA 01/2019 - 01/2018

Therapy/Procedure

123	Therapeutics 04/2024 - 07/2002
27	Percutaneous Coronary Intervention 03/2024 - 09/2004
17	Stents 03/2024 - 01/2009
17	Thrombolytic Therapy 01/2021 - 01/2005
11	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2024 - 04/2007
10	Secondary Prevention 01/2021 - 10/2012
8	Surgical Amputation (Amputations) 10/2023 - 01/2018
5	Patient Readmission 07/2012 - 02/2004